AHI numbers (Alpha Hypopnea Index) are a method doctors use to classify the severity of sleep apnea in a person. Learn more about what these numbers mean for your sleep at WebMD.

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative pressure devices compete?

The Australian Phase 2 trials revealed that the lowest dose achieved a 51% reduction in the Apnea-Hypopnea Index (AHI) on average.

Researchers hypothesized that a composite scoring system for sleep apnea would be a more effective predictor of cardiovascular risk than the standard apnea-hypopnea index.

Apnimed’s obstructive sleep apnea drug reduced breathing interruptions in a Phase 3 clinical trial. The once-nightly pill, which is based on research from Brigham and Women’s Hospital ...

In a multivariable analysis of kids who were undergoing adenotonsillectomy, obstructive Apnea-Hypopnea Index (AHI) scores (which range from ≥5 to ≥30 apnea and hypopnea events per hour) were ...

Veterans with apnea-hypopnea index scores implying no sleep apnea or severe sleep apnea had higher all-cause mortality rates vs. those with mild/moderate sleep apnea, according to data published ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Using the apnea-hypopnea index of AHI3a, which assesses breathing interruptions during sleep, the researchers found that patients on the highest dose of sulthiame had 39.9% lower frequency of ...

Following FDA approval, Apple will shortly launch its sleep apnea detection feature for the Apple Watch, and has now published a health paper detailing its development and verification.